infecti
diseas
develop
world
icu
usual
involv
bacteri
sepsi
result
communityacquir
pneumonia
pelvic
inflammatori
diseas
ruptur
abdomin
viscu
traumat
spontan
necrotis
fasciiti
exot
infect
malaria
despit
import
virus
rare
consid
except
outbreak
hemorrhag
fever
case
shortliv
notorieti
import
viral
infect
africa
often
differ
found
unit
state
america
usa
chapter
focu
viral
hemorrhag
fever
influenza
varicella
viral
hepat
cytomegaloviru
measl
respiratori
synciti
viru
viral
hemorrhag
fever
gener
character
mark
propens
persontoperson
spread
high
mortal
rate
place
highest
biohazard
categori
class
render
liabl
control
state
countri
relev
biosafeti
regul
virus
numer
tabl
chapter
confin
discuss
found
subsaharan
africa
seen
south
america
india
noteworthi
case
hanta
viru
report
africa
particular
hanta
viru
pulmonari
syndrom
virus
known
consid
associ
hemorrhag
fever
fall
three
group
respect
primari
mean
transmiss
reservoir
host
tabl
howev
clinic
manifest
similar
febril
ill
abrupt
onset
usual
short
incub
period
headach
myalgia
lumbar
pain
nausea
vomit
diarrhea
frequent
hematolog
serolog
find
leukopenia
leukocytosi
thrombocytopenia
elev
transaminas
coagul
profil
becom
progress
abnorm
overt
hemorrhag
featur
epistaxi
gingiv
bleed
melena
superven
day
onward
affect
multipl
organ
system
failur
death
ensu
mortal
high
particularli
filovirus
marburg
fatal
rate
ebola
zair
ebola
ivori
coast
intermedi
two
primari
featur
establish
ill
relat
endotheli
damag
hemorrhag
shock
wherea
direct
cytopathogenesi
appear
major
mechan
injuri
extens
necrosi
endotheli
cell
endotheli
dysfunct
like
due
cytokin
releas
part
system
inflammatori
respons
syndrom
hemorrhag
may
relat
dissemin
intravascular
coagulopathi
dic
presenc
hepat
damag
may
confus
pictur
dic
regular
featur
marburg
crimeancongo
hf
less
frequent
arenaviru
infect
shock
occur
consequ
hypovolemia
limit
observ
made
patient
shock
persist
volum
resuscit
contradictori
increas
decreas
system
vascular
resist
report
associ
reduc
cardiac
index
therapi
support
direct
toward
ensur
adequ
oxygen
deliveri
hemorrhag
manag
replac
appropri
clot
factor
platelet
blood
requir
monitor
cardiac
output
mandatori
given
uncertainti
etiolog
hypotens
posit
transfer
human
antibodi
proven
benefit
filoviru
infect
may
valu
cchf
although
control
trial
valu
treatment
junin
viru
reduct
mortal
initi
within
first
day
ill
also
possibl
valu
lassa
viru
infect
promis
result
obtain
intraven
ribavirin
cchf
south
africa
oral
ribavirin
pakistan
discontinu
intraven
prepar
prevent
proper
evalu
particular
valu
lassa
fever
reduct
mortal
begun
within
day
onset
fever
addit
ribavarin
benefit
argentin
hf
caus
junin
viru
reduc
mortal
hantan
viru
caus
hemorrhag
fever
renal
syndrom
asia
nurs
infect
control
critic
possibl
univers
precaut
may
suffici
afford
protect
howev
worri
exist
airborn
transmiss
possibl
document
reston
zair
strain
ebola
viru
monkey
high
level
barrier
nurs
may
prefer
util
isol
protect
cloth
plu
hepafilt
respir
infect
control
extend
transport
specimen
examin
laboratori
procedur
place
manag
materi
influenza
increasingli
recogn
caus
signific
morbid
mortal
commun
particularli
among
pediatr
patient
elderli
virus
subdivid
subtyp
includ
host
origin
geograph
locat
first
isol
strain
number
year
isol
antigen
descript
hemaglutinin
ha
neuraminidas
na
given
parenthet
sinc
major
antigen
shift
occur
subtyp
replac
subtyp
hong
kong
viru
appear
viru
reappear
recent
avian
viru
appear
epidem
abort
latter
case
erad
domest
bird
popul
pneumonia
common
complic
occur
highrisk
patient
includ
comorbid
ill
cardiovascular
pulmonari
diseas
diabet
renal
failur
immunosuppress
elderli
resid
nurs
home
pneumonia
may
primari
viral
origin
secondari
relat
bacteri
infect
primari
viral
pneumonia
sever
although
least
common
pneumon
complic
may
occur
patient
otherwis
normal
wherea
secondari
bacteri
pneumonia
report
frequent
caus
death
previou
pandem
case
recent
outbreak
hong
kong
secondari
bacteri
pneumonia
occur
common
pathogen
pneumonia
aureu
h
influenza
incid
aureu
significantli
increas
influenza
epidem
year
complic
may
result
icu
admiss
rhabdomyolysi
enceph
transvers
myeliti
less
commonli
rey
syndrom
manag
support
though
new
antivir
agent
may
play
role
particularli
administ
earli
current
avail
drug
start
within
day
onset
symptom
effect
practic
effect
drug
oseltamivir
rimantidin
remain
determin
rsv
frequent
encount
potenti
sever
infect
childhood
diseas
less
sever
adult
may
sever
elderli
comorbid
diseas
immunocompromis
present
nonspecif
fever
myalgia
arthralgia
wheez
nonpurul
bloodi
sputum
xray
chang
also
nonspecif
help
etiolog
diagnosi
pneumonia
one
studi
south
africa
patient
admit
hospit
acut
lower
respiratori
tract
infect
identifi
period
pneumonia
diagnos
bronchiol
laryngotracheobronch
moder
sever
diseas
respect
latter
requir
admiss
icu
rsv
enzym
immunoassay
posit
case
group
diagnos
viral
cultur
perform
case
grew
rsv
adenoviru
parainfluenza
influenza
b
diagnosi
made
frequent
rapid
antigen
detect
routin
perform
investig
outsid
research
studi
enzym
immunoassay
sensit
specif
treatment
rsv
support
although
nebul
ribavirin
proven
effect
infant
agent
readili
avail
develop
countri
would
impract
recommend
routin
enzym
test
children
adult
admit
icu
varicella
pneumonia
repres
sever
complic
varicella
frequent
occur
adult
estim
incid
vari
highest
adult
case
overal
incid
region
varicella
pneumonia
report
carri
overal
mortal
howev
mechan
ventil
necessari
mortal
high
risk
factor
includ
cigarett
smoke
pregnanc
immunocompromis
male
gender
wherea
chickenpox
primarili
diseas
childhood
less
report
case
occur
adult
death
take
place
group
recent
evid
indic
upward
shift
age
chicken
pox
contract
consequ
possibl
critic
ill
patient
varicella
may
seen
varicella
pneumonia
caus
interstiti
pneumonia
sever
impair
ga
exchang
patholog
manifest
florid
immun
reaction
character
interstiti
pneumon
mononuclear
cell
infiltr
capillari
endotheli
cell
destruct
intraalveolar
exud
hemorrhag
septal
wall
invas
mononuclear
cell
inflammatori
chang
bronchiol
pneumon
appear
due
host
respons
rather
specif
viral
mediat
tissu
injuri
wherea
usual
therapi
involv
support
acyclovir
benefit
latter
uncertain
possibl
acyclovir
may
hasten
improv
less
ill
requir
ventil
despit
recognit
limit
efficaci
still
wide
recommend
earli
primari
therapi
studi
perform
icu
indic
corticosteroid
may
dramat
alter
cours
sever
diseas
consid
addit
antivir
therapi
along
appropri
support
care
previous
well
patient
life
threaten
varicella
pneumonia
littl
known
incid
clinic
caus
varicella
pneumonia
hiv
human
immunodefici
viru
infect
individu
patient
hiv
aid
acquir
immunodefici
syndrom
hospit
chickenpox
appear
high
risk
develop
varicella
pneumonia
manifest
similar
clinic
fashion
immunocompet
individu
recent
review
conduct
region
infecti
diseas
hospit
affili
institut
patient
hospit
chickenpox
develop
pneumonia
incid
significantli
greater
previous
report
studi
immunocompet
patient
immunocompromis
patient
varicella
pneumonia
previous
report
poorli
mortal
high
despit
prompt
initi
antivir
therapi
support
care
experi
suggest
respons
adjunct
corticosteroid
therapi
patient
hivaid
favor
immunocompet
patient
interestingli
recurr
varicella
pneumonia
requir
acut
treatment
follow
secondari
antivir
prophylaxi
hivinfect
adult
patient
describ
analog
aid
complic
opportunist
infect
proport
viral
hepat
infect
progress
acut
liver
failur
caus
virus
low
occur
less
patient
acut
b
hepat
howev
virus
account
case
liver
failur
relat
hepat
b
hbv
rel
smaller
proport
hav
newli
identifi
virus
fulmin
hepat
failur
defin
either
acut
liver
diseas
occur
absenc
preexist
liver
diseas
lead
encephalopathi
within
week
onset
symptom
liver
diseas
lead
encephalopathi
within
week
onset
jaundic
clinic
featur
often
nonspecif
nausea
vomit
progress
encephalopathi
coma
prognosi
invers
proport
degre
encephalopathi
hepat
rna
viru
transmit
fecalor
rout
hepat
b
dna
viru
account
viral
caus
fulmin
hepat
transmiss
via
sexual
contact
transplacent
parenter
particular
occup
hepat
incomplet
rna
viru
requir
presenc
hepat
b
viru
order
infect
individu
import
caus
fulmin
hepat
aggress
chronic
hepat
hbv
carrier
hepat
e
viru
rna
viru
transmit
fecalor
rout
possibl
parenter
unknown
reason
carri
high
mortal
fulmin
hepat
pregnant
women
also
commonest
caus
fulmin
hepat
india
hepat
c
viru
rna
viru
flavivirida
famili
respons
acut
hepat
chronic
hepat
endstag
cirrhosi
europ
patient
infect
hepat
c
develop
chronic
infect
consist
either
chronic
hepat
fibrosi
cirrhosi
also
usual
caus
fulmin
hepat
failur
occur
area
high
hepat
c
serum
preval
diagnosi
hav
made
basi
detect
high
level
igm
antibodi
serum
fulmin
hepatit
failur
caus
hbv
widespread
hepat
necrosi
occur
consequ
immun
mediat
lysi
infect
hepatocyt
may
result
igm
antihepat
b
core
antihbc
marker
hepat
b
hepat
b
surfac
antigen
hepat
b
dna
may
absent
serum
virus
herp
group
cytomegaloviru
herp
simplex
ebstein
barr
viru
adenoviru
influenza
viru
may
rare
caus
fulmin
hepat
failur
treatment
involv
identif
caus
possibl
specif
therapi
facil
avail
patient
grade
encephalopathi
greater
transfer
liver
transplant
center
support
therapi
involv
hemodynam
manag
ventil
prevent
treatment
hemorrhag
dialysi
therapi
coexist
sepsi
electrolyt
disturb
manag
intracrani
pressur
orthopt
liver
transplant
frequent
avail
develop
countri
appropri
patient
shown
improv
surviv
significantli
measl
frequent
encount
diseas
icu
develop
countri
presenc
malnutrit
often
lack
effect
vaccin
programm
combin
convert
harmless
childhood
infect
major
killer
one
case
seri
patient
admit
icu
measl
epidem
malnourish
none
vaccin
requir
mechan
ventil
pneumonia
ard
die
develop
longterm
sequela
ie
chronic
lung
diseas
subacut
scleros
panenceph
hemiplegia
partial
amput
limb
young
adult
exempt
ravag
diseas
studi
greec
previous
healthi
young
male
hospit
measl
bacteri
pneumonia
admiss
develop
pneumonia
hospit
post
discharg
anoth
studi
adult
patient
admit
measl
diagnos
clinic
serolog
ground
requir
intens
care
six
mechan
ventil
approxim
day
two
death
occur
prior
vaccin
histori
avail
would
best
avoid
measl
entir
mean
vaccin
howev
contract
studi
conduct
south
africa
indic
vitamin
supplement
reduc
morbid
mortal
significantli
conclud
given
regardless
presenc
absenc
clinic
evid
vitamin
defici
herp
enceph
common
caus
fatal
sporad
enceph
unit
state
account
annual
case
viral
enceph
accur
figur
avail
incid
diseas
develop
world
howev
see
sporad
case
icu
diseas
occur
age
group
develop
focal
enceph
progress
oedema
necrosi
syndrom
character
rapid
onset
fever
seizur
focal
neurolog
sign
impair
level
conscious
adult
etiolog
herp
simplex
type
wherea
neonat
type
may
also
involv
confer
wors
outcom
brain
biopsi
longer
routin
diagnost
test
polymeras
chain
reaction
assay
consid
best
noninvas
techniqu
test
posit
earli
diseas
remain
first
week
earli
aggress
antivir
therapi
acyclovir
improv
mortal
reduc
subsequ
cognit
impair
acyclovir
provid
better
outcom
vidaribin
wherea
cmv
usual
asymptomat
sever
morbid
may
occur
prematur
neonat
organ
bone
marrow
transplant
recipi
seroneg
patient
receiv
seroposit
organ
transplant
develop
primari
infect
case
seroposit
patient
develop
cmv
infect
superinfect
reinfect
case
primari
infect
like
type
also
usual
sever
receiv
antithymocyt
antilymphocyt
globulin
bone
marrow
transplant
also
sever
diseas
mortal
cmv
infect
occur
frequent
week
transplant
manifest
includ
fever
hepat
leukopenia
thrombocytopenia
import
condit
result
admiss
icu
interstiti
pneumon
associ
variabl
chang
chest
radiograph
commonli
show
diffus
bilater
infiltr
focal
consolid
nodul
may
occur
develop
world
cmv
frequent
seen
associ
hiv
despit
clear
associ
mortal
organ
transplant
recipi
particular
bone
marrow
transplant
signific
cmv
pathogen
patient
aid
unclear
autopsi
studi
demonstr
although
cmv
pneumon
frequent
present
commonli
found
sole
pathogen
addit
bronchoalveolar
lavag
specimen
also
posit
cmv
patient
cmv
also
report
potenti
caus
ventil
associ
pneumonia
immunocompet
patient
suggest
cmv
consid
possibl
patient
respond
antimicrobi
evid
hospit
outbreak
viral
infect
particularli
pediatr
ward
diagnosi
made
frequent
antigenem
assay
incorpor
antibodi
direct
matrix
protein
cmv
viru
test
gain
accept
particularli
immunocompromis
host
correl
viremia
polymeras
chain
reaction
even
higher
sensit
alway
wide
avail
mainstay
therapi
solid
organ
transplant
ganciclovir
appear
reduc
morbid
contrast
ganciclovir
effect
bone
marrow
transplant
recipi
therefor
use
singl
agent
therapi
patient
possibl
combin
immunoglobulin
cytomegaloviru
immunoglobulin
may
valu
novemb
unusu
respiratori
ill
report
guangdong
provinc
southern
china
design
sever
acut
respiratori
syndrom
sar
subsequ
world
wide
transmiss
initi
doctor
travel
hong
kong
infect
guest
hotel
global
alert
issu
unpreced
step
nevertheless
proven
appropri
day
later
consequ
alert
similar
case
identifi
singapor
canada
earli
intern
recognit
impend
crisi
precipit
part
detail
report
clinician
carlo
urbani
subsequ
demis
sar
local
spread
diseas
occur
vietnam
canada
hong
kong
singapor
china
taiwan
organ
tissu
cultur
isol
electron
microscopi
result
rapid
identif
culprit
viru
novel
coronaviru
distantli
relat
previous
infect
human
like
origin
anim
differ
previous
known
coronavirus
caus
diseas
one
host
speci
wherea
viru
appear
also
acquir
abil
infect
human
high
concentr
viral
dna
sputum
suggest
droplet
spread
main
mode
transmiss
lack
antibodi
gener
commun
indic
viru
circul
wide
human
rapid
sequenc
genom
allow
earli
develop
diagnost
test
number
pcr
protocol
develop
test
high
sensit
neg
test
rule
infect
sar
follow
unusu
pattern
initi
phase
ill
viru
shed
rel
low
shed
peak
respiratori
specimen
stool
around
day
onset
clinic
ill
test
high
sensit
yet
exist
necessari
viru
cultur
extrem
demand
use
rapid
diagnosi
howev
elisa
immunofluoresc
neutral
test
soon
avail
commerci
detect
immun
respons
begin
day
reliabl
antibodi
test
avail
day
follow
onset
symptom
seroconvers
fourfold
rise
titr
indic
recent
infect
diagnost
test
current
sever
limit
extrem
caution
use
exclud
possibl
sar
basi
test
alon
suspici
laboratori
featur
includ
lymphopenia
thrombocytopenia
elev
lactat
dehydrogenas
level
perspect
clinician
local
transmiss
occur
case
communityacquir
pneumonia
suspect
otherwis
travel
histori
affect
countri
contact
infect
patient
essenti
case
definit
suspect
probabl
case
sar
use
resourc
clinic
featur
recent
studi
peiri
patient
becam
apyrexi
within
hour
fever
recur
patient
mean
day
nosocomi
bacteri
sepsi
caus
day
patient
anoth
episod
fever
radiolog
worsen
occur
patient
mean
day
subsequ
improv
remain
unchang
time
write
progress
diffus
ground
glass
appear
mean
day
develop
desatur
less
room
air
day
onset
symptom
requir
icu
mean
day
intub
requir
mechan
ventil
ard
develop
ard
bimod
pattern
peak
day
anoth
day
univari
analysi
risk
factor
develop
ard
age
male
sex
chronic
hepat
b
carriag
rais
creatinin
recurr
fever
igg
seroconvers
sensit
day
even
corticosteroid
therapi
howev
nasopharyng
viral
rna
detect
present
present
studi
lee
admit
icu
respiratori
failur
mechan
ventil
requir
die
coexist
condit
multivari
analysi
defin
age
odd
ratio
per
decad
life
p
high
peak
ldh
per
unit
p
neutrophil
count
exceed
upper
limit
normal
present
predictor
mortal
admit
icu
dramat
increas
lung
opac
short
breath
hypoxia
occur
median
day
rang
studi
booth
admit
icu
die
ie
mortal
diabet
rel
risk
rr
ci
comorbid
condit
rr
independ
associ
outcom
treatment
viral
amplif
may
associ
cellular
damag
cytolysi
immunopatholog
mechan
immun
respons
mount
autoimmun
tissu
injuri
may
occur
rational
corticosteroid
therapi
condit
interestingli
sar
behav
similarli
varicella
diseas
sever
adult
pneumon
manifest
may
occur
day
onset
clinic
symptom
dramat
respons
appar
use
corticosteroid
see
varicella
wherea
concern
regard
use
corticosteroid
also
mani
propon
particularli
coalfac
hong
kong
rivabirin
initi
antivir
choic
sinc
effect
treatment
fulmin
hepat
mice
infect
mous
hepat
corona
viru
howev
antivir
report
clinic
effect
human
drug
extrem
expens
intraven
form
health
canada
recent
state
would
longer
provid
access
ribavirin
side
effect
lack
clear
efficaci
et
al
describ
standard
protocol
manag
sar
involv
administr
combin
ribavirin
corticosteroid
patient
extens
bilater
chest
radiograph
involv
persist
chest
radiograph
involv
high
fever
day
worsen
clinic
radiograph
laboratori
find
oxygen
satur
less
room
air
late
administr
corticosteroid
appear
less
effect
correct
dose
accord
bodi
weight
result
rapid
improv
symptom
obes
patient
stepdown
within
day
result
rebound
patient
steroid
protocol
administ
high
dose
begin
methylprednison
mgkg
mg
x
day
wean
day
mortal
requir
short
period
noninvas
ventil
mortal
revis
initi
estim
case
fatal
rate
basi
complet
data
china
hong
kong
singapor
vietnam
mortal
vari
accord
age
less
age
year
younger
age
age
greater
age
older
infect
control
sar
highli
contagi
specif
health
care
worker
particular
index
case
immedi
identifi
diseas
princ
wale
hospit
patient
admit
pneumonia
discharg
well
howev
health
care
worker
becam
ill
potenti
case
identifi
day
march
patient
admit
princ
wale
hospit
sar
traceabl
index
patient
singapor
similarli
initi
transmiss
occur
index
case
patient
primari
contact
health
care
worker
latter
case
singaporean
media
label
patient
superspread
concept
although
yet
inadequ
defin
may
possibl
correct
patient
appear
spread
diseas
readili
may
relat
rate
shed
viral
particl
toronto
amongst
case
health
care
worker
subsequ
outbreak
least
patient
occur
consequ
cluster
unrecogn
patient
admit
north
york
hospit
toronto
infect
control
measur
includ
neg
pressur
ward
use
mask
glove
time
dispos
imperm
gown
eye
protect
hand
wash
remov
glove
avoid
touch
nose
eye
mouth
possibl
import
practic
measur
hcw
cohort
decreas
number
peopl
expos
visit
strictli
limit
alcohol
phenol
quaternari
ammonium
base
disinfect
highli
activ
coronaviru
certain
featur
appear
enhanc
spread
particular
overcrowd
hospit
ward
outdat
ventil
system
use
nebul
ward
environ
endotrach
intub
open
suction
respiratori
secret
use
bipap
high
frequenc
oscillatori
ventil
air
forc
around
face
mask
appear
highrisk
procedur
numer
sourc
describ
adequ
infect
control
procedur
avail
well
cdc
websit
primari
factor
respons
transmiss
seem
inadequ
train
complianc
infect
control
procedur
wherea
virus
usual
consid
import
caus
icu
admiss
review
demonstr
percept
incorrect
virus
manifest
differ
contin
contin
hemispher
hemispher
essenti
intensivist
familiar
diagnosi
manag
ubiquit
organ
